Cetera Trust Company’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Cetera Trust Company's DGX Position: Q3 2026 in Review
Cetera Trust Company held its Quest Diagnostics (DGX) position steady in Q3 2026 at 30 shares worth $6.99K. The position accounts for ﹤0.01% of the portfolio, ranked #305.
Cetera Trust Company first reported a position in DGX in Q4 2023 and has held it in 12 quarters since. 1,142 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Cetera Trust Company held 30 shares of Quest Diagnostics worth $6.99K as of Q3 2026.
- Cetera Trust Company left its Quest Diagnostics share count unchanged in Q3 2026.
- Quest Diagnostics made up ﹤0.01% of Cetera Trust Company's portfolio in Q3 2026, its #305 holding.
- Cetera Trust Company first reported a position in Quest Diagnostics in Q4 2023 and has held it in 12 quarters since.
- 1,142 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Cetera Trust Company's 13F filing for Q3 2026, filed 9 Nov 2026.